Testosterone Therapy Safe in Hypogonadal Elderly Men
In a study of hypogonadal men older than 65, the treatment did not increase the prevalence of thrombotic events.
In a study of hypogonadal men older than 65, the treatment did not increase the prevalence of thrombotic events.
Patients experienced significant improvements in symptoms and quality of life parameters.
Survey of minority men aged 18-25 showed that 57.2% indicated that they or their partner did not use birth control at their last sexual encounter.
Hypogonadism was present in 42.8% of subjects, yet TRT was used by only 3.9%.
Insertion of these devices decreased from 4.6% of erectile dysfunction cases in 2002 to 2.3% in 2010.